August's top stories: UK hospitals receive £500m, Indian hospital gets $17.5m
Hospitals across the world have received financing - UK has earmarked additional funding of £500m for hospitals in the next two years while Indian Rainbow Hospitals received $17.5m in equity investment.
Humber River Hospital, a Canadian acute care hospital, has received a $10m donation from pharmaceutical company Apotex in support of the hospital's emergency department.
The funding will enable the hospital to expand access to emergency care services for the people of the north-west Greater Toronto Area.
Humber River Hospital Foundation chairman Eddy Battiston said Apotex and its CEO Jack Kay have been integral supporters of the Humber River Hospital Foundation for many years.
WanJiaYuan International Geriatric Hospital in Nanyang, China, has signed an agreement with MentisCura Diagnostics, an Iceland-based diagnostic company, to deploy MentisCura's advanced electrophysiological analytic tools for improving and accelerating the differential diagnosis of CNS disorders.
The WanJiaYuan Hospital, which is expected to open in June 2014, will implement MentisCura's electroencephalogram (EEG)-based diagnostics for enhancing its diagnostic capability for most common types of dementia, including Alzheimer's disease and Lewy body dementia.
MentisCura CEO Kristinn Gretarsson said the high-throughput and non-invasive nature of the company's electrophysiological analysis makes it ideal for real-world clinical settings, where physicians need to assess patients and make care decisions before the disease becomes untreatable.
Dubai Health Authority (DHA) hospitals will equip primary health centres and speciality health centres with Android tablets as part of the 'Smart Government' initiative.
The initiative was launched to promote patient health and generate patient feedback in a quick and efficient manner.
DHA director-general Essa Al Maidoor said the DHA has mapped out a plan towards total IT solutions that will significantly enhance both customer experience and the manner in which healthcare is delivered and managed.
"The deployment of Android tablets across DHA healthcare entities is the first step in our plan to build 'smart hospitals' that will be integrated with the latest IT technology to enhance customer experience," Maidoor added.
CDC, the UK's Development Finance Institution, and The Abraaj Group, a Dubai-based investor firm, have announced a $17.5m equity investment in Rainbow Hospitals, an Indian paediatric and maternity care company.
The investment is expected to help the hospital expand and develop its medical facilities and replicate its pioneering model across the country, in cities such as Bangalore, Chennai and Pune.
Rainbow Hospitals chairman and managing director Dr Ramesh Kancharla said the investment will give the hospital the capacity to expand the number of available beds from the current 450-plus to close to 1,000 by 2017.
The Hong Kong Hospital Authority has granted a project management contract to Aecom Technology, a provider of professional technical and management support services for public and private clients, to re-develop Kwong Wah Hospital in Hong Kong.
Kwong Wah Hospital is one of the major acute hospitals in the Hong Kong Hospital Authority's Kowloon West Cluster.
Scheduled for completion during 2022, the redevelopment plan aims to expand the capacity of the hospital to meet the demand for healthcare services in the region.
The British Prime Minister David Cameron has announced additional funding of £500m for hospitals in the next two years.
The funding, which will also include £15m for the 111 phone service, will be used to improve accident and emergency (A&E) wards.
While some blame the pressure placed on A&E wards on staffing cuts and the wider health service shake-up, David Cameron noted that more than a million more people have visited A&E in the last three years.
Kashiwaba Neurosurgical Hospital in Sapporo, Japan, has treated the first glioblastoma patient in the country with alternating electric field therapy, NovoTTF therapy.
Novocure's technology is being used by the hospital to treat a recurrent glioblastoma tumour, the most common form of primary brain cancer worldwide.
Kashiwaba Neurosurgical Hospital Dr Tatsunori Okamaura said: "NovoTTF therapy was the best treatment option for this patient. We are very pleased with how quickly Novocure responded to our compassionate use request."